SAGE Therapeutics, Inc. (NASDAQ:SAGE) Q3 2021 Results Earnings Conference Call November 2, 2021 8:00 AM ET
Company Participants
Helen Rubenstein - Investor Contact
Barry Greene - Chief Executive Officer
Steve Kanes - Chief Medical Officer
Jim Doherty - Chief Research Officer
Kimi Iguchi - Chief Financial Officer
Conference Call Participants
Ritu Baral - Cowen and Company
Thomas Deal - J.P. Morgan
Paul Matteis - Stifel Financial
Yasmeen Rahimi - Piper Sandler
Ami Fadia - Needham & Company
Andrea Tan - Goldman Sachs
Laura Chico - Wedbush Securities
Matt Hagood - Oppenheimer & Co.
Sumant Kulkarni - Canaccord
Yatin Suneja - Guggenheim Partners
Akash Tewari - Jefferies
Gospel Enyindah-Asonye - Morgan Stanley
Operator
Good morning. Welcome to SAGE Therapeutics Third Quarter 2021 Financial Results Conference Call. Currently, all participants are in a listen-only mode. This call is being webcast live on the Investors & Media section of SAGE’s website at sagerx.com. This call is the property of SAGE Therapeutics and recording, reproduction, or transmission of this call without the express written consent of SAGE Therapeutics is strictly prohibited. Please note that this call is being recorded.
I would now like to introduce Helen Rubinstein, Investor Relations at SAGE.
Helen Rubenstein
Good morning and thank you for joining SAGE Therapeutics third quarter 2021 financial results conference call. Before we begin, I encourage everyone to go to the Investors & Media section of our website at sagerx.com where you can find a press release related to today’s call, as well as the slides that contain supplemental details.
I'd like to point out that we will be making forward-looking statements, which are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. Please consult the risk factors discussed in today’s press release and in our
- Read more current SAGE analysis and news
- View all earnings call transcripts